BioVentrix

Related Content

January 22, 2020 – BioVentrix Inc., developer of the first transcatheter device for left ventricular remodeling after a ...

January 22, 2020

October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S. arm of the ALIVE ...

October 17, 2017

May 31, 2017 — BioVentrix Inc. recently announced the first clinical use of its closed-chest Revivent TC TransCatheter ...

May 31, 2017

March 2, 2017 — BioVentrix Inc. announced that InEk, the German Institute for the Hospital Remuneration System, has ...

March 02, 2017

This video, provided by BioVentrix Inc., demonstrates how to implant the Revivent TC System to reduce the volume of the ...

February 06, 2017

January 10, 2017 — BioVentrix Inc. announced in December the first closed-chest Revivent TC TransCatheter Ventricular ...

January 10, 2017

June 30, 2016 — BioVentrix Inc. announced that it has received certification for CE marking its Revivent TC ...

June 30, 2016

June 1, 2016 — BioVentrix Inc. announced that it has received a U.S. Food and Drug Administration (FDA) Investigational ...

June 01, 2016

May 19, 2016 — BioVentrix announced the first-in-man use of its next-generation Revivent-TC System with an endovascular ...

May 19, 2016

December 29, 2015 — BioVentrix in mid-December announced the successful completion of the 30th clinical case using the ...

December 29, 2015